Net Cash Provided by (Used in) Financing Activities of Merck & Co., Inc. from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Merck & Co., Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • Merck & Co., Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $5,755,000,000, a 105% decline year-over-year.
  • Merck & Co., Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $1,922,000,000, a 73% increase from 2024.
  • Merck & Co., Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $7,032,000,000, a 46% decline from 2023.
  • Merck & Co., Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4,810,000,000, a 47% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

Merck & Co., Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,922,000,000 +$5,110,000,000 +73% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $7,032,000,000 -$2,222,000,000 -46% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $4,810,000,000 +$4,309,000,000 +47% 01 Jan 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
2022 $9,119,000,000 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
2020 $2,832,000,000 +$6,029,000,000 +68% 01 Jan 2020 31 Dec 2020 10-K 25 Feb 2021 2020 FY
2019 $8,861,000,000 +$4,299,000,000 +33% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2021 2020 FY
2018 $13,160,000,000 -$3,154,000,000 -32% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $10,006,000,000 -$962,000,000 -11% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 $9,044,000,000 -$3,657,000,000 -68% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $5,387,000,000 +$9,855,000,000 +65% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $15,242,000,000 -$9,252,000,000 -154% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $5,990,000,000 -$2,723,000,000 -83% 01 Jan 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
2012 $3,267,000,000 +$3,637,000,000 +53% 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015 2014 FY
2011 $6,904,000,000 -$1,463,000,000 -27% 01 Jan 2011 31 Dec 2011 10-K 27 Feb 2014 2013 FY
2010 $5,441,000,000 01 Jan 2010 31 Dec 2010 10-K 28 Feb 2013 2012 FY

Merck & Co., Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $5,755,000,000 -$2,941,000,000 -105% 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q1 2024 $2,814,000,000 -$760,000,000 -37% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025 2025 Q1
Q1 2023 $2,054,000,000 +$1,032,000,000 +33% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024 2024 Q1
Q1 2022 $3,086,000,000 -$988,000,000 -47% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q1 2021 $2,098,000,000 -$608,000,000 -41% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $1,490,000,000 +$124,000,000 +7.7% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q1 2019 $1,614,000,000 +$1,108,000,000 +41% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $2,722,000,000 -$4,183,000,000 -286% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $1,461,000,000 +$4,327,000,000 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q1 2016 $2,866,000,000 -$8,021,000,000 -156% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q1 2015 $5,155,000,000 +$3,535,000,000 +218% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q1 2014 $1,620,000,000 +$3,041,000,000 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q1 2013 $1,421,000,000 -$696,000,000 -96% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q1 2012 $725,000,000 +$447,000,000 +38% 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013 2013 Q1
Q1 2011 $1,172,000,000 -$2,114,000,000 -224% 01 Jan 2011 31 Mar 2011 10-Q 08 May 2012 2012 Q1
Q1 2010 $942,000,000 01 Jan 2010 31 Mar 2010 10-Q 09 May 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.